MACK

Merrimack Pharmaceuticals, Inc.
MACK

Overview Fund Activity
Delisted

MACK was delisted on the 17th of May, 2024.

Back to rankings

50 hedge funds and large institutions have $39.2M invested in Merrimack Pharmaceuticals, Inc. in 2019 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 15 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
50
Holders Change
-4
Holders Change %
-7.41%
% of All Funds
1.09%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
12
Reduced
15
Closed
7
Calls
$232K
Puts
–
Net Calls
+$232K
Net Calls Change
+$171K

Top Buyers

1
NCM
1
Nantahala Capital Management
Connecticut
$3.92M
2
Nuveen Asset Management
2
Nuveen Asset Management
Illinois
$2.87M
3
WSL
3
Western Standard LLC
California
$3.78M
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$2.28M
5
2L
5
22NW LP
Washington
$7.51M

Top Sellers

1
D.E. Shaw & Co
1
D.E. Shaw & Co
New York
$119K
2
CC
2
Cannell & Co
New York
$0
3
JPMorgan Chase & Co
3
JPMorgan Chase & Co
New York
$1K
4
OAM
4
Oxford Asset Management
United Kingdom
$169K
5
Goldman Sachs
5
Goldman Sachs
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Canada Pension Plan Investment Board
51
Canada Pension Plan Investment Board
Ontario, Canada
– -$24K -4,357 Closed
1 2
3